Felbamate in refractory partial epilepsy

Epilepsy Research

Volumn 34, Issue 1, 1999, Pages 43-48

  Canger, Raffaele ^a   Vignoli, Aglaia ^a   Bonardi, Roberta ^b   Guidolin, Loredana ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Schering Plough SpA   (Italy)

Author keywords

Efficacy; Felbamate; Open label study; Partial epilepsy; Refractory epilepsy

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETHOSUXIMIDE; FELBAMATE; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; VALPROIC ACID; VALPROMIDE; VIGABATRIN;

ADOLESCENT; ADULT; AGED; ANOREXIA; ARTICLE; CHILD; CLINICAL ARTICLE; DIPLOPIA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPHAGIA; FEMALE; FOCAL EPILEPSY; HEADACHE; HUMAN; INSOMNIA; IRRITABILITY; MALE; NAUSEA; PRIORITY JOURNAL; VOMITING; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CHILD; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPYLENE GLYCOLS; TREATMENT OUTCOME;

EID: 0033035292     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(98)00098-9     Document Type: Article

References (16)

1. Avanzini G., Canger R., Dalla Bernardina B., Vigevano F. Felbamate Italian Study Group. Felbamate in therapy resistant epilepsy: an Italian Experience. Epilepsy Res. 25:1996;249-255.
2. Bergen D.C., Ristanovic R.K., Waicosky K., Kanner A., Hoeppner T.J. Weight loss in patients taking Felbamate. Clin. Neuropharmacol. 18:1995;122-127.
3. Bourgeois B., Leppik I.E., Sackellares J.C. et al. Felbamate: a double-blind controlled trial in patients undergoing pre-surgical evaluation of partial seizures. Neurology. 43:1993;693-696.
4. Devinsky O., Faught R.E., Wilder B.J. et al. Efficacy of felbamate monotherapy in patients undergoing pre-surgical evaluation of partial seizures. Epilepsy Res. 20:1995;241-246.
5. Faught E., Sachdeo R.C., Remler M.P. et al. Felbamate monotherapy for partial-onset seizures: an active-control trial. Neurology. 43:1993;688-692.
6. Felbamate Study Group in Lennox-Gastaut Syndrome, 1993. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut Syndrome). New Engl. J. Med. 328, 29-33.
7. Kaufman D.W., Kelly J.P., Anderson T., Harmon D.C., Shapiro S. Evaluation of case reports of plastic anaemia among patients treated with felbamate. Epilepsia. 38:1997;1265-1269.
8. Leppik I.E., Dreifuss F.E, Pledger G.W. et al. Felbamate for partial seizures: results of a controlled clinical trial. Neurology. 41:1991;1785-1789.
9. Li L.M., Nashef L., Moriarty J., Duncan J.S., Sander J.W.A.S. Felbamate as add-on therapy. Eur. Neurol. 36:1996;146-148.
10. Nelder J.A., Wedderburn R.W.M. Generalized Linear Models. J. R. Stat. Soc. A. 135:1972;370-384.
11. Pellock J.M., Brodie M.J. Felbamate: 1997 Update. Epilepsia. 38:1997;1261-1264.
12. Rho J.M., Donevain S.D., Rogawski M.A. Mechanism of action of the anti-convulsant felbamate: opposing effects on N-Methyl-d-Aspartate and GABA A receptors. Ann. Neurol. 35:1994;224-234.
13. Riva R., Albani F., Contin M., Baruzzi A. Pharmacokinetic interactions between anti-epileptic drugs - Clinical considerations. Clin. Pharmacokinet. 31(6):1996;460-493.
14. Sachdeo R., Kramer L.D., Rosenberg A., Sachdeo S. Felbamate monotherapy controlled trial in patients with partial onset seizures. Ann. Neurol. 32:1992;386-392.
15. Sachdeo R., Narang-Sachdeo S.K., Shumaker R.C., Perhach J.L., Lyness W.H., Rosenberg A. Tolerability and pharmacokinetics of monotherapy felbamate doses of 1200-6000 mg/day in subjects with epilepsy. Epilepsia. 38:1997;887-892.
16. Theodore W.H., Raubertas R.F., Porter R.J. et al. Felbamate: a clinical trial for complex partial seizures. Epilepsia. 32:1991;392-397.